Following multiple warnings from governments and health organisations, there has been renewed investment, led by the public sector, in the discovery of novel antimicrobials to meet the challenge of rising levels of drug-resistant infection, particularly in the case of resistance to antibiotics. Initiatives have also been announced to support and enable the antibiotic discovery process. In January 2018, the Medicines Discovery Catapult, UK, hosted a symposium: Next Generation Antibiotics Discovery, to consider the latest initiatives and any remaining challenges to inform and guide the international research community and better focus resources to yield a novel class of antibiotic.

在政府和卫生组织的多次警告之后，在公共部门的领导下，人们又进行了新的投资，以发现新型抗菌素，以应对耐药菌感染水平上升的挑战，特别是在对抗生素产生耐药性的情况下。还宣布了支持和启用抗生素发现过程的计划。2018年1月，英国的Medicines Discovery Catapult举办了一个研讨会：``下一代抗生素发现''，以考虑最新举措和任何尚待解决的挑战，以为国际研究界提供信息和指导，并更好地集中资源生产新型抗生素。